"The group has now completed the disposal of its Aerospace operations, which unlocks significant hidden value and focuses the group on its Energy & Medical operations, with net cash per share level with its current share price. We expect proceeds will be partly used in a return of capital and partly on acquisitions; both have the scope to enhance EPS materially. We rebase forecasts for the disposal and pending buyback, while maintaining underlying forecasts for Energy & Medical. We see significant upside to the shares on a 1-2 year basis; with upside to forecasts as M&A activity occurs." finnCapp's note published this morning on Research Tree
Welcome to the new Avingtrans stream forum! Messages posted in the Avingtrans stream will be logged here for posterity.
Latest from the Community...
Latest from the Community...
Latest from the Community...